National Center for Health Research

Last updated
National Center for Health Research
Founded1999
Founder Diana Zuckerman
Type Think tank
FocusConducts and scrutinizes research to improve the health and safety of adults and children.
Location
ProductHealth and medical information and assistance
Key people
Diana Zuckerman, President
Website www.center4research.org OOjs UI icon edit-ltr-progressive.svg

The National Center for Health Research (NCHR) is a Washington, D.C. based non-profit organization founded in 1999. Its stated mission is to conduct, analyze, and explain health research to the public. [1] Diana Zuckerman is President of the NCHR.

Contents

In 2014, the organization changed its name from the National Research Center for Women & Families to the National Center for Health Research.

Research

In February 2011, NCHR staff concluded a study into the various alternative approval processes for medical devices at the Food and Drug Administration (FDA). Authors associated with the NCHR published a study "examining how often the different approval or clearance processes were used for medical devices that were subsequently recalled for life-threatening problems." [2] The study recommended that the FDA needed to apply stricter criteria for approving implanted medical devices and those used to diagnose serious illnesses. This recommendation was also supported by an editorial at the same subject. [3] The study resulted in a hearing by the U.S. House of Representatives.[ citation needed ] [4]

In April 2011, President Diana Zuckerman testified before the U.S. Senate Special Committee on Aging about the study's findings. [5] [ failed verification ]

In 2014, the organization published a study in the JAMA Internal Medicine journal about the scientific evidence submitted to the FDA to support the marketing of implanted medical devices under the agency’s 510(k) review process. The study concluded that most of the implanted devices were not required to submit data from clinical trials or scientific evidence of safety or effectiveness before they could be sold. [6]

In 2017, the NCHR staff published a paper in Milbank Quarterly criticizing the FDA for its failure to safeguard electronic health records and other device software from hacking and other cybersecurity threats. They stated, "current regulations are necessary but not sufficient for ensuring patient safety by identifying and eliminating dangerous defects in software currently on the market". [7] They added that legislative changes resulting from the law entitled the 21st Century Cures Act "will further deregulate health IT, reducing safeguards that facilitate the reporting and timely recall of flawed medical software that could harm patients."

The NCHR published another study in Milbank Quarterly in 2018 called "Diversity in Medical Device Clinical Trials: Do We Know What Works for Which Patients?". [8] The study investigated whether new, high-risk medical devices had been proven safe and effective for women, minorities or patients over 65 years of age. The paper concluded that most studies did not conduct subgroup analysis on all these major demographic groups, thus providing no information about safety or effectiveness for most patients. [8]

Awards

Two awards are given by the Center each year:

Publications

References

  1. "Home Page". National Center for Health Research. Retrieved 2022-09-08.
  2. Zuckerman, Diana M.; Brown, Paul; Nissen, Steven E. (13 June 2011). "Medical Device Recalls and the FDA Approval Process". Archives of Internal Medicine. 171 (11): 1006–11. doi:10.1001/archinternmed.2011.30. PMID   21321283.
  3. Redberg, Rita F.; Dhruva, Sanket S. (13 June 2011). "Medical Device Recalls: Get It Right the First Time". Archives of Internal Medicine. 171 (11): 1011–2. doi:10.1001/archinternmed.2011.27. PMID   21321286.
  4. {{cite web}}: Empty citation (help)
  5. "Home - United States Senate Special Committee on Aging". United States Senate . Retrieved 8 August 2015.
  6. Jin, Jill (2014-01-22). "FDA Authorization of Medical Devices". JAMA. 311 (4): 435. doi:10.1001/jama.2013.286274. ISSN   0098-7484. PMID   24449330.
  7. Ronquillo, Jay G.; Zuckerman, Diana M. (September 2017). "Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health". The Milbank Quarterly. 95 (3): 535–553. doi:10.1111/1468-0009.12278. PMC   5594275 . PMID   28895231.
  8. 1 2 Fox-Rawlings, Stephanie R.; Gottschalk, Laura B.; Doamekpor, Laurén A.; Zuckerman, Diana M. (September 2018). "Diversity in Medical Device Clinical Trials: Do We Know What Works for Which Patients?". The Milbank Quarterly. 96 (3): 499–529. doi:10.1111/1468-0009.12344. PMC   6131322 . PMID   30203600.
  9. 1 2 "Foremother and Health Policy Hero Awards Luncheon". National Center for Health Research. 7 May 2018. Retrieved 17 September 2019.